Novo Nordisk on Monday said it is suing online telehealth provider Hims & Hers for mass marketing cheaper, unapproved copies of the drugmaker’s new Wegovy obesity…
More Magnificent Seven earnings are coming next week, helping to decide the direction of a stock market that’s becoming more discerning, while the latest data on…
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading…
We’re buying 200 shares of Nike at roughly $59. Following Wednesday’s trade, Jim Cramer’s Charitable Trust will own 1,600 shares of NKE, increasing its weighting to…
The Eli Lilly & Co. logo at the company’s Digital Health Innovation Hub facility in Singapore, on Thursday, Nov. 14, 2024.Ore Huiying | Bloomberg | Getty…
A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024.Scott Olson | Getty ImagesEli Lilly reached…
The Novo Nordisk A/S headquarters in Bagsvaerd, Denmark, on Wednesday, Nov. 5, 2025. Nichlas Pollier | Bloomberg | Getty ImagesShares of Novo Nordisk on Monday fell…
Stocks bounced back Friday, but not enough to recover the week’s earlier losses. All three major averages posted gains — with the Dow Jones Industrial Average…
It was a volatile week for the stock market, with the Dow Jones Industrial Average hitting an all-time high before pulling back. Wall Street pulled money…
A combination image shows an injection pen of Zepbound, Eli Lilly’s weight loss drug, and boxes of Wegovy, made by Novo Nordisk. Hollie Adams | ReutersThe…